Reuters logo
BRIEF-Celon Pharma Can Start Phase I Clinical Study Of Esketamine-Based Drug
November 28, 2017 / 12:54 PM / 18 days ago

BRIEF-Celon Pharma Can Start Phase I Clinical Study Of Esketamine-Based Drug

Nov 28 (Reuters) - CELON PHARMA SA:

* GETS PERMISSION FOR STARTING PHASE I CLINICAL STUDY FOR ITS DRUG BASED ON ESKETAMINE

* PLANS TO END PHASE I CLINICAL STUDY OF ESKETAMINE-BASED DRUG IN APRIL, 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below